Human VAMP8 (EDB) knockout A-431 cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
VAMP8 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9 X = 4 bp deletion Frameshift = 99.7%.
View Alternative Names
ED B, Endobrevin, VAMP8_HUMAN, Vesicle-associated membrane protein 8
- WB
Lab
Western blot - Human VAMP8 (EDB) knockout A-431 cell lysate (AB270707)
Lane 1 : Wild-type A431 cell lysate 20 ug
Lane 2 : VAMP8 knockout A431 cell lysate 20 ug
Lane 3 : THP-1 cell lysate 20 ug
Lane 4 : SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate 20 ug
Lanes 1 - 4 : Merged signal (red and green). Green - ab76021 observed at 13 kDa. Red - loading control, ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab76021 was shown to react with VAMP8/EDB in wild-type A-431 cells in western blot Loss of signal was observed when VAMP8 knockout cell line ab269584 (knockout cell lysate ab270707) was used. Wild-type and VAMP8 knockout A-431 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab76021 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-VAMP8/EDB antibody [EP2629Y] (<a href='/en-us/products/primary-antibodies/vamp8-edb-antibody-ep2629y-ab76021'>ab76021</a>) at 1/10000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
VAMP8 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human VAMP8 (EDB) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-vamp8-edb-knockout-a-431-cell-line-ab269584'>ab269584</a>)
Lane 3:
THP-1 (Human monocytic leukemia cell line) whole cell lysate at 20 µg
Lane 4:
SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 20 µg
Predicted band size: 11 kDa
Observed band size: 13 kDa
false
- NGS
Supplier Data
Next Generation Sequencing - Human VAMP8 (EDB) knockout A-431 cell lysate (AB270707)
Knockout achieved by CRISPR/Cas9; X = 4 bp deletion; Frameshift = 99.7%
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
VAMP8 engages in vesicular transport mechanisms that support exocytosis and endocytosis processes. It forms part of the SNARE complex which is important for merging vesicles with their target compartments. Through this association VAMP8 aids the release of substances such as hormones and digestive enzymes from the cells. This process is critical for maintaining the balance and function of cellular activities across different tissues.
Pathways
VAMP8 functions in the context of the trafficking pathways that include the endocytic and exocytic pathways. It is a participant in regulated exocytosis where it interacts with other SNARE proteins like syntaxin and SNAP-25 ensuring precise membrane fusion events occur. These pathways ensure proper cellular communication and debris clearance underlining the importance of VAMP8 in general cellular homeostasis.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com